Pillstats
Rx only · Solution/ Drops · Ophthalmic

Brimonidine Tartrate, Timolol Maleate

Brands: Combigan · Brimonidine Tartrate + Timolol Maleate

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US1 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)134615
US makers1 labelers
Packages4
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$11.26$22.53$33.79$45.06Dec 2025Apr 2026Jul 2026
$39.122
Latest avg · Jul 22, 2026
-0%
Since Dec 17, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

8.2K16K25K33K2025 Q12025 Q22025 Q32025 Q42026 Q1
26K
Rx · 2026 Q1
191K
Units dispensed
-5%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Allergan, Inc.unknown4SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Mar 19, 2019
    RECALLRecall (Class II): Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% 5 mL bottles, Rx only, Allergan, Inc. Ir…

    cGMP Deviations — Recalling firm: Allergan Sales, LLC — TN only

  • Oct 19, 2017
    RECALLRecall (Class III): Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%, Rx only, packaged in a) 2.5 mL NDC# 0023…

    Failed Impurities/Degradation Specifications. — Recalling firm: Allergan Sales, LLC — Nationwide and Barbados, Curacao, Dominican Republic, Guyana, Jamaica, and Trinidad and Tobago.